If You Invested in Surgery Partners Inc (SGRY)

Surgery Partners, Inc. (NASDAQ: SGRY) is a healthcare services company focused on short-stay and outpatient surgical care. According to company disclosures, Surgery Partners operates with a differentiated outpatient delivery model that emphasizes high-quality, cost-effective surgical and related ancillary care in support of both patients and physicians. The company is headquartered in Brentwood, Tennessee and was founded in 2004.

Surgery Partners states that it is one of the largest and fastest growing surgical services businesses in the United States, with more than 200 locations in 30 states. Its network includes ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. Across this network, the company positions itself as a short-stay surgical facility owner and operator, concentrating on procedures that can be delivered efficiently in outpatient or limited-stay settings.

Business model and operations

The company describes its model as an integrated outpatient delivery platform. It focuses on providing surgical and related ancillary care through facilities that include ambulatory surgery centers and surgical hospitals, as well as multi-specialty physician practices and urgent care locations. Surgery Partners also operates through a wholly owned subsidiary, Surgery Center Holdings, Inc., which is the issuer of certain senior unsecured notes and term loans referenced in the company’s SEC filings.

Surgery Partners reports that it earns revenues from contracts with patients where the performance obligation is to provide healthcare services. Its network of short-stay facilities is designed to support physicians and patients by offering surgical care in settings outside of traditional inpatient hospital environments. The company’s public communications emphasize cost-effectiveness and clinical quality as central elements of its approach.

Scale and facility footprint

In its public releases, Surgery Partners notes that it operates more than 200 locations across 30 states. These locations span:

• Ambulatory surgery centers
• Surgical hospitals
• Multi-specialty physician practices
• Urgent care facilities

The company also discloses the number of surgical facilities and consolidated surgical facilities in its quarterly financial data. For example, it has reported over 160 surgical facilities and more than 100 consolidated surgical facilities as of period-end in recent filings, underscoring the breadth of its operating footprint in outpatient and short-stay surgical care.

Capital structure and financing activities

Surgery Partners’ capital structure includes senior unsecured notes and term loans issued through Surgery Center Holdings, Inc. SEC filings describe a series of 7.250% senior notes due 2032, initially issued in April 2024 and subsequently increased by an additional $425.0 million aggregate principal amount in December 2025. These notes are guaranteed on a senior unsecured basis by certain domestic wholly owned subsidiaries that also guarantee the issuer’s senior secured credit facilities.

The company has also entered into a credit agreement that provides term loans and revolving credit commitments. A second amendment to this credit agreement, as disclosed in an 8-K filing, introduced a new tranche of refinancing term loans and refinanced revolving credit commitments with stated maturities in 2028 and 2030. These financing arrangements are part of the company’s broader approach to funding operations, refinancing existing debt and supporting its network of surgical facilities.

Strategic partnerships and joint ventures

Surgery Partners engages in joint ventures and partnerships with health systems and physicians. A notable example disclosed in recent news is a joint venture with Baylor Scott & White Health, described as the largest not-for-profit health system in Texas. Under this arrangement, Surgery Partners and Baylor Scott & White, together with physicians, jointly own a 16-bed hospital in Bryan, Texas, known as The Physicians Centre Hospital. The hospital is expected to operate under the Baylor Scott & White name, while Surgery Partners continues to manage daily operations.

The facility in this joint venture offers a broad range of surgical options, including bariatric, ophthalmologic, oral/maxillofacial, orthopedic, gastroenterological, podiatric, spinal and urologic procedures. It also provides general, plastic and reconstructive surgery, sports medicine, pain management and radiology services. This example illustrates how Surgery Partners participates in physician-aligned and health system-aligned structures to expand access to surgical care.

Positioning in outpatient and short-stay surgery

In its earnings releases and other communications, Surgery Partners describes itself as a leading short-stay surgical facility owner and operator. The company highlights the performance of its ambulatory surgery and surgical hospital network through metrics such as same-facility revenue growth, case growth and revenue per case. It also references the role of orthopedic procedures and other core service lines in underpinning its revenue trends.

Surgery Partners’ management commentary in public releases emphasizes operational execution, portfolio performance and the use of mergers and acquisitions, de novo facility development and joint ventures as levers to expand its platform. The company also notes that it evaluates portfolio optimization opportunities and its M&A pipeline as part of its long-term growth approach.

Regulatory and reporting environment

Surgery Partners is listed on The Nasdaq Global Select Market under the ticker symbol SGRY. As a public company, it files periodic reports, current reports on Form 8-K and other disclosures with the U.S. Securities and Exchange Commission. These filings include financial statements, non-GAAP reconciliations, discussions of risk factors and descriptions of material definitive agreements, debt instruments and governance changes.

The company’s disclosures frequently reference the regulatory and reimbursement environment in which it operates, including payments from government healthcare programs and private insurance payors, as well as the impact of healthcare legislation and regulatory reform. It also discusses risks related to physician relationships, supply chain, cybersecurity, and compliance with healthcare laws and regulations in its risk factor sections.

Corporate governance and leadership changes

SEC filings show that Surgery Partners periodically reports changes in its board of directors and executive leadership. For example, the company has disclosed the resignation of an executive chairman of the board and the appointment of a new chairman, as well as the planned resignation of a National Group President. It has also reported the appointment of a Chief Operating Officer and National Group President, including reference to an associated employment agreement filed as an exhibit. These governance disclosures provide insight into how the company manages leadership transitions while maintaining its operational and strategic focus.

Investor communications and performance metrics

Surgery Partners regularly issues earnings releases for its quarterly results and provides guidance ranges for full-year revenues and Adjusted EBITDA. In these communications, the company discusses revenue growth, same-facility revenues, case volumes, Adjusted EBITDA and related non-GAAP measures. It also discloses information about liquidity, including cash and cash equivalents and borrowing capacity under its revolving credit facility, as well as leverage ratios calculated under its credit agreement.

The company explains that non-GAAP measures such as Adjusted EBITDA and Adjusted net income are used by management as supplemental indicators of operating performance and are reconciled to the most directly comparable GAAP measures in its releases. These metrics are presented alongside GAAP results to provide additional context on the performance of its short-stay surgical platform.

Stock information and sector classification

Surgery Partners’ common stock, with a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades under the symbol SGRY on The Nasdaq Global Select Market. Based on the industry and sector information provided, the company operates within the general medical and surgical hospitals industry and the broader health care and social assistance sector, with a specific focus on outpatient and short-stay surgical services.